QuickView for Arylamine N-acetyltransferase (biogroup)

1. Response of breast tumors treated with docetaxel-capecitabine (+/- trastuzumab)
2. Breast cancer response to doxorubicin and docetaxel
3. Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes
4. Blastocysts derived from different Xist knockout and normal somatic cell nuclear donor cells
5. Gene expression in breast cancer samples with mutant PTEN, PIK3CA, ER, or HER2

There were no matches for Arylamine N-acetyltransferase

1. Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2)
2. Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)
3. Acetylamantadine Excretion by Cancer Patients
4. NAT2 in Re-challenge of INH in Patients With Hepatitis